The discovery and development of new antibody therapies and vaccines require knowing the epitope that the antibody interacts with. Regulatory bodies including the FDA and EMEA now require the specific binding sites between an antibody drug and its target to be included in the regulatory filing. GenScript provides a peptide based epitope mapping service with speedy turnaround time.
Service Highlights:
Proprietary advanced FlexPeptide? technology
Optimized detection to minimize nonspecific interactions
High-throughput epitope profiling for a large number of candidate antibodies against a defined target
Speedy delivery, starting from 4 weeks
Service Highlights:
Proprietary advanced FlexPeptide? technology
Optimized detection to minimize nonspecific interactions
High-throughput epitope profiling for a large number of candidate antibodies against a defined target
Speedy delivery, starting from 4 weeks